Algernon Pharmaceuticals Inc.
AGN
CNSX
11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -42.17% | -1.12% | 695.02% | 2.93% | -40.91% |
Total Receivables | -17.24% | 73.13% | -70.74% | 116.04% | -85.07% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -58.62% | 88.00% | 327.35% | -52.24% | -72.06% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -44.49% | 8.74% | 454.52% | 1.23% | -64.26% |
|
|||||
Total Current Assets | -44.49% | 8.74% | 454.52% | 1.23% | -64.26% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -2.97% | 1.07% | -16.86% | 0.03% | -0.15% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -3.76% | 0.95% | -0.47% | 0.00% | -50.12% |
Total Assets | -10.75% | 2.43% | -2.05% | 0.07% | -6.03% |
|
|||||
Total Accounts Payable | 1.07% | 0.75% | -44.92% | 10.81% | 5.75% |
Total Accrued Expenses | 17.06% | -86.55% | -49.56% | 371.05% | 339.67% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 1.27% | -7.04% | -45.37% | 19.67% | 7.76% |
|
|||||
Total Current Liabilities | 1.27% | -7.04% | -45.37% | 19.67% | 7.76% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 1.27% | -7.04% | -45.37% | 19.67% | 7.76% |
|
|||||
Common Stock & APIC | -3.68% | 2.55% | -0.42% | 3.41% | -0.26% |
Retained Earnings | 2.60% | -2.17% | 5.03% | -1.81% | -1.43% |
Treasury Stock & Other | -4.76% | 4.49% | 1.06% | -23.16% | 1.20% |
Total Common Equity | -20.60% | 11.74% | 346.34% | -56.82% | -31.48% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -20.60% | 11.74% | 346.34% | -56.82% | -31.48% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -20.60% | 11.74% | 346.34% | -56.82% | -31.48% |
|